Insider Trading Arrangements |
3 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | Other than the Rule 10b5-1 Trading Plans adopted by (i) Yu-Hsin Lin, our Chief Executive Officer, on December 23, 2025, (ii) Hao-Yuan Chuang, our Chief Financial Officer, on December 22, 2025; (iii) Nathan L. Mata, our Chief Scientific Officer, on December 10, 2025; and (iv) Wan-Shan Chen, our director, on December 23, 2025, we do not have any outstanding share repurchase or automatic trading plan in place. |
| Yu-Hsin Lin | |
| Trading Arrangements, by Individual | |
| Name | Yu-Hsin Lin |
| Title | Chief Executive Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | December 23, 2025 |
| Hao-Yuan Chuang | |
| Trading Arrangements, by Individual | |
| Name | Hao-Yuan Chuang |
| Title | Chief Financial Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | December 22, 2025 |
| Nathan L. Mata | |
| Trading Arrangements, by Individual | |
| Name | Nathan L. Mata |
| Title | Chief Scientific Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | December 10, 2025 |
| Wan-Shan Chen | |
| Trading Arrangements, by Individual | |
| Name | Wan-Shan Chen |
| Title | director |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | December 23, 2025 |